UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLUMBIA

ST. LUKE’S HOSPITAL,

Plaintiff,

v.

KATHLEEN SEBELIUS, Secretary,

Health and Human Services,

Defendant.

:

:

:

:

:

:

:

:

:

:

 Civil Action No. 08-0883 (JR)

MEMORANDUM

Allentown Osteopathic Medical Center, a Medicare

provider, merged with St. Luke’s Hospital on January 1, 1997. 

St. Luke’s, the surviving entity, sought to recover from Medicare

a “loss” on Allentown’s depreciable assets that it asserts was

recognized in the merger. That claim was denied by the assigned

Medicare intermediary on the ground that the merger was not a

“bona fide sale.” The Provider Reimbursement Review Board

reversed that decision on appeal, but was itself overruled by the

Administrator for the Centers for Medicare and Medicaid Services. 

Before the court are cross motions for summary judgment on St.

Luke’s challenge to that final determination.

Background

Before merging with St. Luke’s, Allentown was a nonprofit hospital in Allentown, Pennsylvania certified as a

Medicare “provider of services.” A.R. 2, 434. Allentown began

to encounter economic difficulties, and lost about $1.3 million 

in the year before the merger. A.R. 248, 1339. Not only was
 St. Luke’s takes issue with the use of these assets by the 1

Administrator, but because neither St. Luke’s nor Allentown made

any effort to appraise Allentown’s assets before the transaction,

the Administrator had no other numbers to use –- and neither does

this Court. St. Luke’s argues that Allentown’s contingent

liabilities should have been added into the mix of consideration,

but it has failed to provide any evidence of what those

contingent liabilities are or what they are worth, and in any

event Allentown warranted as part of the merger that it had no

contingent liabilities. A.R. 1120-21.

- 2 -

Allentown losing money, but its facilities were also in need of

an upgrade it could not afford. Pl. MSJ at 9-10.

Allentown thus began searching for potential

“affiliation partners” and hired KPMG Peat Marwick LLP to help

find them. Pl. MSJ at 10. St. Luke’s promised to upgrade

Allentown’s facilities and made qualified promises to keep

Allentown an in-patient, acute-care hospital, and so a deal was

struck. A.R. 245-46; 253; 676-78. The merger occurred on

January 1, 1997 with St. Luke’s as the surviving entity. A.R.

260-63; 564-65. Title to all of Allentown’s assets passed to St.

Luke’s, and St. Luke’s became responsible for Allentown’s $4.8

million in known liabilities. A.R. 447. At the time of the

merger, Allentown’s financial statements valued its assets at

$25.1 million, including $8.5 million in current and monetary

assets. A.R. 448; 573. 1

Medicare functions (believe it or not) by paying

providers based on the cost of procedures –- incentivizing the

use of as many procedures as possible. Providers are

compensated, not for results, but for “the reasonable cost of
- 3 -

[Medicare] services,” 42 U.S.C. § 1395(b)(1), i.e., “the cost

actually incurred . . . [as] determined in accordance with

regulations” promulgated by the Secretary, 42 U.S.C.

§ 1395x(v)(1)(A). One such cost is the “depreciation on

buildings and equipment used in the provision of patient care.” 

42 C.F.R. § 413.134(a). Depreciation allowances are paid

annually by taking “the cost incurred by the present owner in

acquiring the asset,” id. § 413.134(b)(1), dividing that purchase

price by the asset’s estimated useful life, id. § 413.134(a)(3),

and dividing again by the percentage of the asset’s use devoted

to Medicare services. Thus, a million dollar machine estimated

to last ten years that is used on Medicare patients 50 percent of

the time would depreciate at $100,000 per year, and would receive

an allowance from Medicare of $50,000 per year. At the end of

any given year, the asset has a “net book value,” which is the

purchase price minus depreciation from previous years. Thus,

after three years of use, our hypothetical million dollar machine

would have a net book value of $700,000. In theory, that net

book value represents the fair-market price that asset could yet

fetch if sold or treated as an asset in a merger.

The Medicare regulations in effect at the time of the

Allentown merger recognized that this was only theory, however,

and thus provided that when a capital asset was actually disposed

of, either Medicare or the provider could recoup the Medicare-
 Recognizing the endless potential for gamesmanship of the 2

kind at issue here, Congress eliminated reimbursement of losses

as of December 1, 1997. See Balanced Budget Act of 1997, Pub. L.

No. 105-33, § 4404 (A.R. 1713-14). CMMS then amended Medicare

regulations to eliminate reimbursement of losses. 63 Fed. Reg.

1379, 1380-82 (Jan. 9, 1998).

- 4 -

related difference between the value realized in the disposition

and the net book value. According to those regulations, when 2

two unrelated entities combine pursuant to a statutory merger --

which was the manner in which Allentown and St. Luke’s

combined -- any “realization of gains and losses” is “subject to

the provisions of [42 C.F.R. § 413.134(f)].” 42. C.F.R.

§ 413.134(k) (formerly 42 C.F.R. § 413.134(l)). Under section

413.134(f), gains and losses from the disposition of depreciable

assets are treated differently depending on the manner of the

disposition. At issue here is whether the Allentown merger

accomplished a “bona fide sale,” which may result in a gain or

loss for Medicare purposes depending on whether the purchase

price actually paid was greater or less than the net book value.

On October 19, 2000, the Secretary of CMMS issued

Program Memorandum A-00-76, which addressed the application of 42

C.F.R. § 413.134(k). A.R. 944. The Program Memorandum

clarified the Secretary’s interpretation of section 413.124(k),

explaining that mergers would be subject to the “bona fide sale”

requirement, and defining a “bona fide sale” as an arm’s length

transaction for reasonable consideration. A.R. 944; 947. The

memorandum specifically noted that the interpretation was
- 5 -

justified partly because non-profits may combine with other

entities for reasons “that may differ from the traditional forprofit merger or consolidation” and that are not “driven by the

ownership equity interests to seek fair market value for the

assets involved in the transaction.” A.R. 945-46. The Program

Memorandum therefore emphasized that -- just like combinations of

for-profit entities -- mergers that involve non-profits must be

arm’s length transactions for reasonable consideration if gains

or losses on depreciable assets are to be realized for Medicare

purposes. A.R. 947.

After the merger, St. Luke’s submitted a cost claim to

Medicare. The claim was for $2.9 million, representing

depreciation on Allentown’s assets that had never been booked or

claimed in annual depreciation allowances. Because the only

consideration St. Luke’s gave for the assets it acquired in the

merger was its assumption of some $4.8 million of Allentown’s

liabilities, and because this amount fell short of the net book

value remaining on Allentown’s assets, St. Luke’s claimed that

the transfer of these depreciated assets represented a “loss” to

Allentown compensable by Medicare at $2.9 million. A.R. 63. 

And, because Allentown was now a part of St. Luke’s, it was St.

Luke’s that could request reimbursement.

St. Luke’s claim was first submitted to a paid

contractor known as a Medicare fiscal intermediary, see 42 U.S.C. 
- 6 -

§ 1395h, which denied the claim on the ground that the merger was

not a bona fide sale. A.R. 1997. St. Luke’s administratively

appealed to the PRRM, which reversed the bona fide sale

determination and remanded. A.R. 69. The Administrator of CMMS,

relying in part on the Program Memorandum, reversed again. A.R.

2-22. The Administrator held that Allentown did not receive

reasonable consideration for its assets, that the merger was not

an arm’s length transaction, and that the merger therefore failed

to qualify as a bona fide sale from which Allentown had suffered

any compensable costs. A.R. 20-22. St. Luke’s challenges that

final determination in this action.

Analysis

Review of CMMS’s determination is governed by 42 U.S.C.

§ 1396oo(f)(1), which incorporates the Administrative Procedure

Act, 5 U.S.C. § 706: final agency action may be set aside only

when “arbitrary, capricious, an abuse of discretion, or otherwise

not in accordance with the law” or when “unsupported by

substantial evidence.” And under familiar principles of agency

review, an agency’s interpretation of its own rule is entitled to

the utmost deference. See Ballard v. C.I.R., 544 U.S. 40, 70

(2005) (“An agency’s interpretation of its own rule or regulation

is entitled to “controlling weight unless it is plainly erroneous

or inconsistent with the regulation.” (internal quotations

omitted)). “This ‘broad deference’ is especially warranted
- 7 -

[here] because Medicare regulations are ‘complex and highly

technical’ and determinations in this area ‘necessarily require

significant expertise and entail the exercise of judgment

grounded in policy concerns.’” Robert F. Kennedy Med. Ctr. v.

Leavitt, 526 F.3d 557, 562 (9th Cir. 2008) (quoting Thomas

Jefferson University v. Shalala, 512 U.S. 504, 512 (1994)). 

St. Luke’s primary argument for overturning the

Administrator’s decision is that the Secretary’s interpretation

making statutory mergers subject to the bona fide sale

requirement is plainly contrary to the regulations. Three courts

of appeal have already disagreed with this argument. See Albert

Einstein Med. Ctr. v. Sebelius, 566 F.3d 368, 376-77 (3rd Cir.

2009); Robert F. Kennedy, 526 F.3d 557, 560-61; Via Christi Reg'l

Med. Ctr. v. Leavitt, 509 F.3d 1259 (10th Cir. 2007). That

consensus is not surprising: the Secretary’s interpretation is

supported by the text of the regulations and by common sense.

At the time of the merger, 42 C.F.R. § 413.134(k)(2)(I)

provided that “the realization of gains and loses” from a

statutory merger between unrelated entities is “subject to the

provisions of [42 C.F.R. § 413.134(f)].” Section

413.134(k)(2)(ii) provided that no revaluation of assets was

allowed for mergers between related parties. St. Luke’s position

is that, because it was unrelated to Allentown, no other

impediment stood between it and the realization of a gain or loss
- 8 -

from the merger –- including section 413.134(f). But it is

plainly consistent with the text of the regulation to apply the

requirements of section 413.134(f) to a statutory merger between

unrelated parties, because the regulations themselves say that

realization of gains and losses from such a merger are subject to

that section.

At the time of the merger, 42 C.F.R. § 413.134(f)

provided that “[d]epreciable assets may be disposed of through

sale, scrapping, trade-in, exchange, demolition, abandonment,

condemnation, fire, theft, or other casualty,” and “[t]he

treatment of the gain or loss depends upon the manner of

disposition of the asset.” Of the types of disposal specified,

the only one that could arguably apply to a merger is a sale. 

But section 413.134(f)(2) allows for the realization of gains or

losses only upon a “bona fide sale.” The reason for this

requirement is obvious –- only an arm’s length transaction for

reasonable consideration ensures that the purchase price is a

better reflection of actual value than the net book value. If

the sale is not a bona fide, free-market exchange, the purchase

price may be only an illusion, designed to make the asset appear

to have lost more value than it really has. As the Ninth Circuit

recently explained:

Providers are entitled to reimbursement only for

the “cost actually incurred” in servicing Medicare

patients. 42 U.S.C. § 1395x(v)(1)(A). As the

Secretary noted when promulgating 42 C.F.R.
- 9 -

§ 413.134(f), “if a gain or loss is realized from

[a] disposition, reimbursement for depreciation

must be adjusted so that Medicare pays the actual

cost the provider incurred.” See Principles of

Reimbursement for Provider Costs and for Services

by Hospital-based Physicians, 44 Fed. Reg. 3980

(Jan. 19, 1979) (emphasis added). The Secretary's

requirements of “reasonable consideration” and

“fair market value” ensure that Medicare reimburses

actual costs, instead of providing a windfall to

providers.

Robert F. Kennedy, 526 F.3d at 562; see also Albert Einstein, 566

F.3d at 376-77; Via Christi Reg’l, 509 F.3d at 1274-77 (“Even if

a consolidation or statutory merger is not a ‘sale’ per se,

treating it as a sale pursuant to § 413.134(f)(2) ensures that

any depreciation adjustment will represent economic reality,

rather than mere ‘paper losses.’”). Thus, the Secretary’s policy

is far more reasonable than St. Luke’s proposal -- i.e., that

depreciation be recalculated every time there is a merger even

when the amount of assumed liabilities and other consideration

bears no recognizable relationship to the actual depreciation

incurred. A.R. 944-47.

St. Luke’s argues that the Secretary’s bona fide sale

requirement makes it impossible for St. Luke’s to have realized a

loss or a gain as a result of the merger –- that there would have

no point in paying a market price for Allentown’s depreciable

assets because, as the surviving entity, St. Luke’s would merely

have reabsorbed that payment after the merger. That may be true. 

But it is true only because the actual sale “price” in this
- 10 -

merger –- the assumption of a non-profit’s current liabilities in

order to keep it operating –- had nothing to do with the

reasonable value of the non-profit’s long-term assets. The

Secretary’s interpretation does not mean that no statutory merger

can ever result in revaluation of depreciable assets. If a

merger involved the assumption of liabilities that closely

mirrored the true value of depreciable assets, or involved

competitive bidding for those assets, it might satisfy the bona

fide sale requirements, even if it involved a non-profit entity

like Allentown. But where, as here, even the plaintiff agrees

that the “price” provides no reasonable estimate of market value,

see Pl. MSJ 17-18 (“[I]t would be mere happenstance if the fair

market value of the merged entity’s assets was equal to its known

liabilities for which the surviving entity would become

responsible.”), it would be odd indeed for Medicare to treat the

liabilities assumed as a better estimation of market price than

the assets’ net book value.

A large part of St. Luke’s argument is that the

Secretary’s interpretation is a post hoc rationalization -- that

the Secretary changed signals in this case, departing from a

previous policy that all statutory mergers automatically trigger

the reassessment of depreciable assets. St. Luke’s purports to

find that old policy in “informal agency interpretations,” Pl.

MSJ at 21 n.5, reflected in two letters and a portion the
- 11 -

Medicare Intermediary Manual in effect at the time of the merger. 

A.R. 531, 1500-01. Even if those informal sources do stand for

the proposition that CMMS did not previously subject statutory

mergers to any bona fide sale requirement –- and the issue is at

least unclear, see, e.g., Albert Einstein, 566 F.3d at 376 –- St.

Luke’s claim of error founders on the principle that agencies may

change their informal interpretations at any time, so long as

their new position is adequately explained. See, e.g., FCC v.

Fox Television Stations, Inc., 129 S. Ct. 1800, 1811 (2009)

(“[T]he agency must show that there are good reasons for the new

policy. But it need not demonstrate to a court’s satisfaction

that the reasons for the new policy are better than the reasons

for the old one; it suffices that the new policy is permissible

under the statute, that there are good reasons for it, and that

the agency believes it to be better, which the conscious change

of course adequately indicates.”). The Program Memorandum

explains that applying the bona fide sales requirement to

statutory mergers is necessary because many mergers are not

“driven by the ownership equity interests to seek fair market

value for the assets involved in the transaction” and so will not

reflect the fair market value of assets any better than the net

book value. A.R. 945-46. That rationale is sufficient –- posthoc or not –- to support the interpretation at issue here.
- 12 -

St. Luke’s also argues that the Secretary’s change of

course required a new rulemaking, subject to notice and comment. 

But interpretative clarifications do not require notice and

comment. 5 U.S.C. § 553(b)(A). Nor can there be any doubt that

the policy at issue here is properly an informal interpretation.

See Albert Einstein, 566 F.3d at 381 (finding this change only an

interpretive clarification); Via Christi Reg’l, 509 F.3d at 1271

n.11 (same). The materials identified by St. Luke’s to

substantiate the existence of a prior policy are themselves

informal interpretations, and the bona fide sales requirement

comes straight from the text of the existing rule itself. See 42

C.F.R. § 413.132(f)(2).

St. Luke’s makes three sundry arguments that may be

quickly disposed of. Its argument that the Deficit Reduction Act

of 1984 precluded the Secretary from interpreting his regulations

after that date is unsupported by the text of that act or any

case law in its motion. Its argument that Secretary failed to

timely list the Program Memorandum in the Federal Register fails

because St. Luke’s has failed to show prejudice from this error. 

See 5. U.S.C. § 706. And its argument that the Secretary failed

to submit its interpretation to the House and Senate is precluded

from judicial review. Montanans for Multiple Use v. Barbouletos,

568 F.3d 225, 229 (D.C. Cir. 2009).
- 13 -

The only question left, then, is whether the

Secretary’s finding that the St. Luke’s merger was not a bona

fide sale was supported by substantial evidence. It clearly was. 

The sizable gap between the “purchase price” and the value of

Allentown’s assets and the other circumstances surrounding the

merger are sufficient to support the Administrator’s ruling. At

the time of the merger, Allentown’s current and monetary assets

alone were nearly double the value of the liabilities assumed;

its total assets were more than five times the “price”. The

Administrator’s finding is thus supported by more than

substantial evidence, and in fact well demonstrates why a bona

fide sales requirement is necessary to prevent Medicare from

making payments that bear no relation to actual costs. See

Albert Einstein, 566 F.3d 368; Robert F. Kennedy, 526 F.3d 557,

560-61; Via Christi Reg'l, 509 F.3d at 1277.

 JAMES ROBERTSON

United States District Judge